newsfilter
← Latest News
GlobeNewswire·

Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development

TORONTO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (NASDAQ:FTRP, TSX:FTRP) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies, today announced that the U.S. Patent and Trademark Office (USPTO) has is